Exhibiting at the Oncology Convention

Ekso Bionics Europe GmbH

Ekso GT™ is the first exoskeleton cleared by the U.S. FDA and receive a CE Mark in Europe for use with stroke and spinal cord injuries from L5 to C7. The EksoGT with SmartAssist™ software is the only exoskeleton available for rehabilitation institutions that can provide adaptive amounts of power to either side of the patient`s body, challenging the patient as they progress through their continuum of care. The suit`s patented technology provides the ability to mobilize patients earlier, more frequently and with a greater number of high intensity steps. To date, this device has helped patients take more than 84 million steps in over 170 rehabilitation institutions around the world.

Visit Website


Exhibitor product 1Exhibitor product 2Exhibitor product 3